Tag: infusion therapy devices market scope

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Infusion Therapy Devices Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?

The market for infusion therapy devices has experienced rapid expansion in recent years. This sector is forecast to grow from $13.33 billion in 2025 to $14.74 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.5%. The historical increase in this market can be attributed to several factors, including the rising incidence of chronic diseases, an increase in hospital admissions that require infusion therapy, the wider availability of oncology and diabetes treatments, the growing adoption of intravenous drug delivery, and improved accessibility to infusion devices.

The infusion therapy devices market size is poised for substantial expansion in the coming years. By 2030, this market is projected to reach $21.82 billion, demonstrating a compound annual growth rate (CAGR) of 10.3%. This anticipated growth during the forecast period is driven by several factors, including the escalating demand for home healthcare services, the increasing adoption of connected medical devices, the broader application of personalized medicine delivery, an intensified effort to minimize medication errors, and greater capital expenditure in smart hospital infrastructure. Key developments expected in the forecast period encompass a surge in the embrace of smart infusion pumps, a heightened need for portable and ambulatory infusion devices, the expanding integration of dose error reduction systems, a proliferation of home-based infusion therapy, and a reinforced emphasis on patient safety and monitoring.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=14456247&type=smp&name=Infusion%20Therapy%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Infusion Therapy Devices Market Growth Catalysts And Demand Drivers

The escalating incidence of chronic diseases is anticipated to drive the expansion of the infusion therapy devices market in the foreseeable future. Chronic diseases are defined as long-term health conditions that persist for a year or more, necessitating continuous medical attention or limiting daily activities. The growing prevalence of these conditions can be attributed to poor lifestyle choices, sedentary habits, unhealthy diets, and environmental factors, alongside an increase in risk factors such as obesity, smoking, and stress. Infusion therapy devices facilitate the management of chronic diseases by enabling the precise and controlled delivery of medications and fluids directly into the bloodstream, thereby ensuring consistent and effective treatment for conditions like diabetes, autoimmune disorders, and cancer. This process improves patient outcomes, enhances convenience, and lessens the need for frequent hospital visits. For example, in January 2023, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, projected that by the year 2050, the number of individuals aged 50 years and above with at least one chronic illness will increase by 99.5%, rising from 71.522 million in 2020 to 142.66 million. Consequently, the increasing prevalence of chronic diseases is fueling the growth of the infusion therapy devices market.

Infusion Therapy Devices Market Segment Analysis Spotlighting Growth Areas

The infusion therapy devices market covered in this report is segmented –

1) By Product: Infusion Pumps, Intravenous (Iv) Sets, Cannulas, Needleless Connectors

2) By Mobility: Portable Infusion Pumps, Stationary Pumps

3) By Application: Oncology, Diabetes, Pain Management, Other Applications

4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Homecare, Other End-Users

Subsegments:

1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Insulin Infusion Pumps

2) By Intravenous (IV) Sets: Standard IV Sets, Extension IV Sets, IV Administration Sets with Filters

3) By Cannulas: Peripheral Intravenous (PIV) Cannulas, Central Venous Cannulas, Butterfly Cannulas

4) By Needleless Connectors: Positive Pressure Needleless Connectors, Neutral Pressure Needleless Connectors, Negative Pressure Needleless Connectors

Infusion Therapy Devices Market Trends Shaping Long-Term Demand

Leading companies in the infusion therapy devices market are concentrating on developing innovative solutions, such as pressure-enabled drug delivery (PEDD) technology, to improve the treatment of liver and pancreatic tumors. Pressure-enabled drug delivery (PEDD) describes a drug delivery technique that employs pressure to enhance the infusion of therapeutic agents into tissues or organs, particularly in areas where conventional methods present challenges. For instance, in November 2024, TriSalus Life Sciences, a US-based medical technology company, launched the TriNav LV Infusion System and TriGuide Guiding Catheters. This expanded its pressure-enabled drug delivery (PEDD) portfolio, aiming to optimize therapeutic delivery, thus broadening treatment options and potentially improving outcomes for patients. The TriNav LV Infusion System incorporates unique features such as its suitability for larger blood vessels (3.5 to 5.0 mm), thereby extending the application of TriSalus’ Pressure-Enabled Drug Delivery (PEDD) technology to a broader patient population. This launch expands PEDD device compatibility from 1.5 mm to 5.0 mm vessels, offering interventional radiologists more treatment alternatives. TriGuide Guiding Catheters are characterized by a larger inner diameter, a lubricious lining, and a reverse curve design, which facilitates easier femoral access and enhances procedural efficiency. Early users have reported a 97% satisfaction rate, highlighting the system’s effectiveness and ease of use in oncology treatments.

Infusion Therapy Devices Market Competitive Landscape: Which Companies Lead The Industry?

Major companies operating in the infusion therapy devices market are Roche Holding AG, Fresenius Kabi AG, Medtronic plc, Medline Industries Inc., Baxter International Inc., Terumo Corporation, Mindray Medical International Limited, Nipro Corporation, ICU Medical Inc., Cook Medical, LivaNova PLC, Vygon S.A., AngioDynamics Inc., B. Braun Melsungen AG, Moog Medical Devices Group, Kangaroo, Vantage Medical Technologies, Alaris Medical Systems Inc., Smiths Medical, Teleflex Incorporated

View The Full Infusion Therapy Devices Market Report:

https://thebusinessresearchcompany.com/report/infusion-therapy-devices-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Infusion Therapy Devices Market Regional Breakdown: Where Is Demand Concentrated?

North America was the largest region in the infusion therapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infusion therapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Infusion Therapy Devices Market Change Between 2026 And 2030?

The infusion therapy devices market has demonstrated rapid expansion in recent years. It is anticipated to grow from $13.33 billion in 2025 to $14.74 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.5%. Historically, this market’s growth has been fueled by the increasing prevalence of chronic diseases, a rise in hospital admissions requiring infusion therapy, the expansion of oncology and diabetes treatments, the growing application of intravenous drug delivery, and enhanced availability of infusion devices.

The infusion therapy devices market size is projected to experience swift expansion over the coming years, with expectations to reach $21.82 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.3%. This growth during the forecast period can be attributed to several factors, including the escalating demand for home healthcare services, the growing acceptance of connected medical devices, the broader application of personalized medicine delivery, a heightened emphasis on minimizing medication errors, and increased financial commitments towards smart hospital infrastructure. Key trends anticipated over the forecast period encompass the wider utilization of smart infusion pumps, a surge in the need for portable and ambulatory infusion devices, the expanding incorporation of dose error reduction systems, the growth of home-based infusion therapy, and a stronger emphasis on ensuring patient safety and effective monitoring.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20849&type=smp

Which Drivers Are Advancing The Infusion Therapy Devices Market Growth?

The rising occurrence of chronic illnesses is anticipated to boost the expansion of the infusion therapy devices market in the future. Chronic diseases are defined as enduring health conditions lasting at least a year, necessitating continuous medical care or restricting daily activities. This increase in chronic disease prevalence stems from factors like unhealthy lifestyle choices, inactive routines, poor dietary habits, and environmental impacts, alongside a surge in risk elements such as obesity, smoking, and stress. Infusion therapy devices play a crucial role in managing chronic conditions by facilitating the accurate and regulated administration of medications and fluids straight into the bloodstream. This method ensures consistent and effective treatment for ailments including diabetes, autoimmune disorders, and cancer, leading to better patient outcomes, increased convenience, and fewer hospital visits. As an illustration, data from the US-based National Library of Medicine, the National Center for Biotechnology Information (NCBI), published in January 2023, predicts a substantial increase of 99.5% by 2050 in individuals aged 50 and older suffering from at least one chronic illness, climbing from 71.522 million in 2020 to 142.66 million. Consequently, the expanding incidence of chronic diseases is a key factor propelling the growth within the infusion therapy devices market.

How Are Different Segment Groups Identified Within The Infusion Therapy Devices Market?

The infusion therapy devices market covered in this report is segmented –

1) By Product: Infusion Pumps, Intravenous (Iv) Sets, Cannulas, Needleless Connectors

2) By Mobility: Portable Infusion Pumps, Stationary Pumps

3) By Application: Oncology, Diabetes, Pain Management, Other Applications

4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Homecare, Other End-Users

Subsegments:

1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Insulin Infusion Pumps

2) By Intravenous (IV) Sets: Standard IV Sets, Extension IV Sets, IV Administration Sets with Filters

3) By Cannulas: Peripheral Intravenous (PIV) Cannulas, Central Venous Cannulas, Butterfly Cannulas

4) By Needleless Connectors: Positive Pressure Needleless Connectors, Neutral Pressure Needleless Connectors, Negative Pressure Needleless Connectors

Which Trends Are Supporting The Evolution Of The Infusion Therapy Devices Market?

Leading firms within the infusion therapy devices market are concentrating on creating advanced solutions, particularly pressure-enabled drug delivery (PEDD) technology, to improve how liver and pancreatic tumors are treated. PEDD, or pressure-enabled drug delivery, is a method that employs pressure to boost the delivery of therapeutic agents into tissues or organs, especially beneficial in regions where standard approaches might be less effective. As an example, in November 2024, TriSalus Life Sciences, a medical technology firm based in the US, introduced the TriNav LV Infusion System and TriGuide Guiding Catheters. This launch expanded its pressure-enabled drug delivery (PEDD) offerings, aiming to optimize therapeutic administration, thereby broadening treatment choices and potentially bettering patient results. The TriNav LV Infusion System provides distinct features like accommodating larger blood vessels, ranging from 3.5 to 5.0 mm, which extends the application of TriSalus’ Pressure-Enabled Drug Delivery (PEDD) technology to a wider patient demographic. This introduction broadens PEDD device compatibility from 1.5 mm to 5.0 mm vessels, providing interventional radiologists with an increased array of treatment possibilities. The TriGuide Guiding Catheters are characterized by a larger inner diameter, a smooth, lubricious lining, and a reverse curve design, facilitating easier femoral access and boosting procedural efficiency. Initial users have reported a 97% satisfaction rate, underscoring the system’s efficacy and user-friendliness in oncology treatments.

Which Key Players Are Active In The Infusion Therapy Devices Market?

Major companies operating in the infusion therapy devices market are Roche Holding AG, Fresenius Kabi AG, Medtronic plc, Medline Industries Inc., Baxter International Inc., Terumo Corporation, Mindray Medical International Limited, Nipro Corporation, ICU Medical Inc., Cook Medical, LivaNova PLC, Vygon S.A., AngioDynamics Inc., B. Braun Melsungen AG, Moog Medical Devices Group, Kangaroo, Vantage Medical Technologies, Alaris Medical Systems Inc., Smiths Medical, Teleflex Incorporated

Access The Complete Infusion Therapy Devices Market Report:

https://www.thebusinessresearchcompany.com/report/infusion-therapy-devices-global-market-report

Which Region Accounts For The Highest Share Of The Infusion Therapy Devices Market?

North America was the largest region in the infusion therapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infusion therapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Infusion Therapy Devices Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/infusion-therapy-devices-global-market-report

Browse Through More Reports Similar to the Global Infusion Therapy Devices Market 2026, By The Business Research Company

Cigarette Filters Market Report 2026

https://www.thebusinessresearchcompany.com/report/cigarette-filters-global-market-report

Bag Filter Market Report 2026

https://www.thebusinessresearchcompany.com/report/bag-filter-global-market-report

Filters Market Report 2026

https://www.thebusinessresearchcompany.com/report/filters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Infusion Therapy Devices Market Expected To Scale Between 2026 And 2030?

The infusion therapy devices market size has experienced significant expansion in recent years. It is anticipated to grow from $13.33 billion in 2025 to $14.74 billion in 2026, at a compound annual growth rate (CAGR) of 10.5%. The historical growth of this market can be attributed to factors such as the increasing prevalence of chronic diseases, a rise in hospital admissions necessitating infusion therapy, the expansion of oncology and diabetes treatments, the growing adoption of intravenous drug delivery, and enhanced availability of infusion devices.

The infusion therapy devices market is anticipated to experience significant expansion over the next few years. It is projected to achieve a value of $21.82 billion by 2030, growing at a compound annual growth rate (CAGR) of 10.3%. This projected growth is driven by factors such as the increasing demand for home healthcare services, the rising adoption of connected medical devices, the expansion of personalized medicine delivery, a heightened focus on reducing medication errors, and growing investments in smart hospital infrastructure. Prominent trends for the forecast period include the increasing adoption of smart infusion pumps, a rising demand for portable and ambulatory infusion devices, the growing integration of dose error reduction systems, the expansion of home-based infusion therapy, and an enhanced focus on patient safety and monitoring.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20849&type=smp

What Factors Are Contributing To The Growth Of The Infusion Therapy Devices Market?

The increasing prevalence of chronic diseases is anticipated to propel the growth of the infusion therapy devices market in the future. Chronic diseases are defined as long-lasting health conditions persisting for a year or more, necessitating ongoing medical attention or limiting daily activities. This rise in chronic illness prevalence can be attributed to poor lifestyle choices, sedentary habits, unhealthy diets, environmental influences, and an increase in risk factors such as obesity, smoking, and stress. Infusion therapy devices effectively manage these conditions by ensuring the precise and controlled delivery of medications and fluids directly into the bloodstream, providing consistent and effective treatment for ailments like diabetes, autoimmune disorders, and cancer. This leads to improved patient outcomes, greater convenience, and a reduced need for frequent hospital visits. For instance, in January 2023, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, projected a 99.5% surge in the number of individuals aged 50 years and above with at least one chronic illness by 2050, increasing from 71.522 million in 2020 to 142.66 million. Consequently, the rising prevalence of chronic diseases is a significant driver for the growth of the infusion therapy devices market.

Which Segment Types Are Examined In The Infusion Therapy Devices Market Segment Study?

The infusion therapy devices market covered in this report is segmented –

1) By Product: Infusion Pumps, Intravenous (Iv) Sets, Cannulas, Needleless Connectors

2) By Mobility: Portable Infusion Pumps, Stationary Pumps

3) By Application: Oncology, Diabetes, Pain Management, Other Applications

4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Homecare, Other End-Users

Subsegments:

1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Insulin Infusion Pumps

2) By Intravenous (IV) Sets: Standard IV Sets, Extension IV Sets, IV Administration Sets with Filters

3) By Cannulas: Peripheral Intravenous (PIV) Cannulas, Central Venous Cannulas, Butterfly Cannulas

4) By Needleless Connectors: Positive Pressure Needleless Connectors, Neutral Pressure Needleless Connectors, Negative Pressure Needleless Connectors

What Trends Are Shaping The Future Of The Infusion Therapy Devices Market?

Leading companies in the infusion therapy devices market are concentrating on developing innovative solutions, such as pressure-enabled drug delivery (PEDD) technology, to enhance the treatment of liver and pancreatic tumors. Pressure-enabled drug delivery (PEDD) refers to a drug delivery method that utilizes pressure to improve the infusion of therapeutic agents into tissues or organs, especially in areas where conventional approaches may encounter difficulties. For example, in November 2024, TriSalus Life Sciences, a US-based medical technology company, launched the TriNav LV Infusion System and TriGuide Guiding Catheters. This expanded its pressure-enabled drug delivery (PEDD) portfolio to optimize therapeutic delivery, enhancing treatment options and potentially improving patient outcomes. The TriNav LV Infusion System offers unique features, such as compatibility with larger blood vessels (3.5 to 5.0 mm), thereby extending the use of TriSalus’ Pressure-Enabled Drug Delivery (PEDD) technology to a broader patient population. This launch expands PEDD device compatibility from 1.5 mm to 5.0 mm vessels, providing interventional radiologists with more treatment options. TriGuide Guiding Catheters incorporate a larger inner diameter, a lubricious lining, and a reverse curve design for easier femoral access and improved procedural efficiency. Early users have reported a 97% satisfaction rate, emphasizing the system’s effectiveness and ease of use in oncology treatments.

Which Players Are Part Of The Competitive Landscape Of The Infusion Therapy Devices Market?

Major companies operating in the infusion therapy devices market are Roche Holding AG, Fresenius Kabi AG, Medtronic plc, Medline Industries Inc., Baxter International Inc., Terumo Corporation, Mindray Medical International Limited, Nipro Corporation, ICU Medical Inc., Cook Medical, LivaNova PLC, Vygon S.A., AngioDynamics Inc., B. Braun Melsungen AG, Moog Medical Devices Group, Kangaroo, Vantage Medical Technologies, Alaris Medical Systems Inc., Smiths Medical, Teleflex Incorporated

Get The Full Infusion Therapy Devices Market Report:

https://www.thebusinessresearchcompany.com/report/infusion-therapy-devices-global-market-report

Which Region Leads The Infusion Therapy Devices Market In Overall Market Size?

North America was the largest region in the infusion therapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infusion therapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Infusion Therapy Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=20849&type=smp

Browse Through More Reports Similar to the Global Infusion Therapy Devices Market 2026, By The Business Research Company

Cigarette Filters Market Report 2026

https://www.thebusinessresearchcompany.com/report/cigarette-filters-global-market-report

Bag Filter Market Report 2026

https://www.thebusinessresearchcompany.com/report/bag-filter-global-market-report

Filters Market Report 2026

https://www.thebusinessresearchcompany.com/report/filters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Infusion Therapy Devices Market Evolve From 2026 To 2030?

The infusion therapy devices market has experienced significant expansion in recent years. This market is projected to increase from $13.33 billion in 2025 to $14.74 billion in 2026, showing a compound annual growth rate (CAGR) of 10.5%. The historical growth in this sector is attributable to the rising prevalence of chronic diseases, an uptick in hospital admissions needing infusion therapy, the broadening of oncology and diabetes treatments, the growing application of intravenous drug delivery, and enhanced availability of infusion devices.

The infusion therapy devices market size is anticipated to expand significantly in the coming years. It is projected to reach $21.82 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 10.3%. The projected growth during this period is largely attributable to the increasing demand for home healthcare services, the growing adoption of connected medical devices, the expansion of personalized medicine delivery, a greater focus on reducing medication errors, and increased investments in smart hospital infrastructure. Moreover, significant trends expected in the forecast period include the rising adoption of smart infusion pumps, increasing demand for portable and ambulatory infusion devices, expanding integration of dose error reduction systems, the broader expansion of home-based infusion therapy, and an enhanced emphasis on patient safety and monitoring.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20849&type=smp

What Key Drivers Are Influencing The Growth Of The Infusion Therapy Devices Market?

The growing incidence of chronic diseases is anticipated to drive the expansion of the infusion therapy devices market in the future. These are defined as health conditions enduring for a minimum of one year, necessitating continuous medical management or restricting daily activities. The rise in chronic disease prevalence stems from factors like unhealthy lifestyle decisions, inactive routines, poor dietary habits, and environmental impacts, alongside a surge in risk elements including obesity, smoking, and stress. Infusion therapy devices play a crucial role in managing chronic diseases by facilitating the accurate and regulated administration of medications and fluids directly into the circulatory system. This ensures dependable and effective treatment for various conditions such as diabetes, autoimmune disorders, and cancer, ultimately leading to better patient results, increased ease of use, and fewer hospitalizations. For example, data from January 2023 by the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, forecasts that by 2050, the population aged 50 years and above with at least one chronic illness will see a 99.5% increase, climbing from 71.522 million in 2020 to 142.66 million. Consequently, the growing occurrence of chronic diseases is a key driver for the expansion of the infusion therapy devices market.

Which Segment Areas Are Covered In The Infusion Therapy Devices Market Analysis?

The infusion therapy devices market covered in this report is segmented –

1) By Product: Infusion Pumps, Intravenous (Iv) Sets, Cannulas, Needleless Connectors

2) By Mobility: Portable Infusion Pumps, Stationary Pumps

3) By Application: Oncology, Diabetes, Pain Management, Other Applications

4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Homecare, Other End-Users

Subsegments:

1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Insulin Infusion Pumps

2) By Intravenous (IV) Sets: Standard IV Sets, Extension IV Sets, IV Administration Sets with Filters

3) By Cannulas: Peripheral Intravenous (PIV) Cannulas, Central Venous Cannulas, Butterfly Cannulas

4) By Needleless Connectors: Positive Pressure Needleless Connectors, Neutral Pressure Needleless Connectors, Negative Pressure Needleless Connectors

What Key Developments And Trends Are Impacting The Infusion Therapy Devices Market?

Leading companies in the infusion therapy devices market are concentrating on developing innovative solutions, such as pressure-enabled drug delivery (PEDD) technology, to improve the treatment of liver and pancreatic tumors. Pressure-enabled drug delivery (PEDD) is a drug delivery technology that uses pressure to enhance the infusion of therapeutic agents into tissues or organs, particularly where conventional methods may face challenges. For instance, in November 2024, TriSalus Life Sciences, a US-based medical technology company, launched the TriNav LV Infusion System and TriGuide Guiding Catheters, thereby expanding its pressure-enabled drug delivery (PEDD) portfolio to optimize therapeutic delivery, enhance treatment options, and potentially improve outcomes for patients. The TriNav LV Infusion System offers unique features such as its compatibility with larger blood vessels (3.5 to 5.0 mm), expanding the use of TriSalus’ Pressure-Enabled Drug Delivery (PEDD) technology to a broader patient population. This launch extends PEDD device compatibility from 1.5 mm to 5.0 mm vessels, providing interventional radiologists with more treatment options. TriGuide Guiding Catheters feature a larger inner diameter, a lubricious lining, and a reverse curve design for easier femoral access and improved procedural efficiency. Early users have reported a 97% satisfaction rate, highlighting the system’s effectiveness and ease of use in oncology treatments.

Which Global Companies Are Actively Competing In The Infusion Therapy Devices Market?

Major companies operating in the infusion therapy devices market are Roche Holding AG, Fresenius Kabi AG, Medtronic plc, Medline Industries Inc., Baxter International Inc., Terumo Corporation, Mindray Medical International Limited, Nipro Corporation, ICU Medical Inc., Cook Medical, LivaNova PLC, Vygon S.A., AngioDynamics Inc., B. Braun Melsungen AG, Moog Medical Devices Group, Kangaroo, Vantage Medical Technologies, Alaris Medical Systems Inc., Smiths Medical, Teleflex Incorporated

Read the full infusion therapy devices market report here:

https://www.thebusinessresearchcompany.com/report/infusion-therapy-devices-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Infusion Therapy Devices Market?

North America was the largest region in the infusion therapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infusion therapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Infusion Therapy Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20849&type=smp

Browse Through More Reports Similar to the Global Infusion Therapy Devices Market 2026, By The Business Research Company

Cigarette Filters Market Report 2026

https://www.thebusinessresearchcompany.com/report/cigarette-filters-global-market-report

Bag Filter Market Report 2026

https://www.thebusinessresearchcompany.com/report/bag-filter-global-market-report

Filters Market Report 2026

https://www.thebusinessresearchcompany.com/report/filters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Infusion Therapy Devices Market by the end of 2030?

The infusion therapy devices market has seen substantial growth recently. It is forecast to expand from $13.33 billion in 2025 to $14.74 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.5%. The market’s past development can be linked to the rising occurrence of chronic illnesses, an increase in hospital admissions needing infusion therapy, the broadening of oncology and diabetes treatments, greater adoption of intravenous drug delivery, and enhanced availability of infusion devices.

The infusion therapy devices market is projected to experience significant expansion over the coming years. This market is anticipated to reach $21.82 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.3%. Factors contributing to this growth during the projected period include the escalating demand for home healthcare services, the increased uptake of connected medical devices, the broadening scope of personalized medicine delivery, an intensified focus on minimizing medication errors, and greater investments in smart hospital infrastructure. Key trends expected in the forecast timeframe encompass the expanding use of smart infusion pumps, a growing need for portable and ambulatory infusion devices, the increased integration of dose error reduction systems, the widening implementation of home-based infusion therapy, and a heightened emphasis on patient safety and monitoring.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20849&type=smp

What Drivers Are Shaping Future Opportunities In The Infusion Therapy Devices Market?

The escalating occurrence of chronic diseases is set to drive the growth of the infusion therapy devices market. Chronic diseases are characterized as long-term health conditions that persist for a year or more, demanding ongoing medical attention or restricting daily activities. The rising prevalence of these conditions can stem from factors such as poor lifestyle choices, sedentary habits, unhealthy diets, and environmental influences, as well as an increase in risk factors like obesity, smoking, and stress. Infusion therapy devices help manage chronic diseases by delivering medications and fluids precisely and controllably directly into the bloodstream, thus ensuring consistent and effective treatment for conditions including diabetes, autoimmune disorders, and cancer, which in turn improves patient outcomes, boosts convenience, and reduces the need for frequent hospital visits. For example, in January 2023, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, projected that by 2050, the number of individuals aged 50 years and above with at least one chronic illness will increase by 99.5%, climbing from 71.522 million in 2020 to 142.66 million. Thus, the increasing prevalence of chronic diseases is propelling the expansion of the infusion therapy devices market.

Which Segment Groups Are Influencing The Infusion Therapy Devices Market?

The infusion therapy devices market covered in this report is segmented –

1) By Product: Infusion Pumps, Intravenous (Iv) Sets, Cannulas, Needleless Connectors

2) By Mobility: Portable Infusion Pumps, Stationary Pumps

3) By Application: Oncology, Diabetes, Pain Management, Other Applications

4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Homecare, Other End-Users

Subsegments:

1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Insulin Infusion Pumps

2) By Intravenous (IV) Sets: Standard IV Sets, Extension IV Sets, IV Administration Sets with Filters

3) By Cannulas: Peripheral Intravenous (PIV) Cannulas, Central Venous Cannulas, Butterfly Cannulas

4) By Needleless Connectors: Positive Pressure Needleless Connectors, Neutral Pressure Needleless Connectors, Negative Pressure Needleless Connectors

What Trends Are Projected To Support The Growth Of The Infusion Therapy Devices Market?

Key players in the infusion therapy devices market are concentrating on creating advanced solutions, including pressure-enabled drug delivery (PEDD) technology, to improve the treatment of liver and pancreatic tumors. Pressure-enabled drug delivery (PEDD) describes a drug delivery method that leverages pressure to boost the infusion of therapeutic agents into tissues or organs, especially in regions where traditional approaches might encounter difficulties. For example, in November 2024, TriSalus Life Sciences, a US-based medical technology company, introduced the TriNav LV Infusion System and TriGuide Guiding Catheters, thereby expanding its pressure-enabled drug delivery (PEDD) offerings to optimize therapeutic delivery, which broadens treatment options and could potentially enhance patient outcomes. The TriNav LV Infusion System provides distinct features like accommodating larger blood vessels (3.5 to 5.0 mm), thus extending the application of TriSalus’ Pressure-Enabled Drug Delivery (PEDD) technology to a wider range of patients. This introduction broadens PEDD device compatibility from 1.5 mm to 5.0 mm vessels, furnishing interventional radiologists with an increased array of treatment possibilities. TriGuide Guiding Catheters are characterized by a larger inner diameter, a lubricious lining, and a reverse curve design, facilitating easier femoral access and enhancing procedural efficiency. Initial users have reported a 97% satisfaction rate, underscoring the system’s efficacy and user-friendliness in oncology treatments.

Who Are The Prominent Global Companies Shaping The Infusion Therapy Devices Market Landscape?

Major companies operating in the infusion therapy devices market are Roche Holding AG, Fresenius Kabi AG, Medtronic plc, Medline Industries Inc., Baxter International Inc., Terumo Corporation, Mindray Medical International Limited, Nipro Corporation, ICU Medical Inc., Cook Medical, LivaNova PLC, Vygon S.A., AngioDynamics Inc., B. Braun Melsungen AG, Moog Medical Devices Group, Kangaroo, Vantage Medical Technologies, Alaris Medical Systems Inc., Smiths Medical, Teleflex Incorporated

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/infusion-therapy-devices-global-market-report

Which Region Currently Holds The Largest Share Of The Infusion Therapy Devices Market?

North America was the largest region in the infusion therapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infusion therapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Infusion Therapy Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20849&type=smp

Browse Through More Reports Similar to the Global Infusion Therapy Devices Market 2026, By The Business Research Company

Cigarette Filters Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cigarette-filters-global-market-report

Bag Filter Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/bag-filter-global-market-report

Filters Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/filters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Infusion Therapy Devices Industry In 2025?

The market for infusion therapy apparatus has experienced swift expansion lately, projected to escalate from a valuation of $12.1 billion in 2024 to $13.33 billion by the subsequent year, reflecting a compounded annual growth trajectory of 10.2%; this upswing during the past timeframe is fundamentally linked to a rise in patient admissions to healthcare facilities, advancements in medical groundwork, supportive governmental programs, the expansion of medical travel, and supportive mechanisms for reimbursement.

Projections indicate that the market for infusion therapy devices is poised for swift expansion in the years ahead, reaching a valuation of $19.82 billion by 2029, driven by a compound annual growth rate (CAGR) of 10.4%.This upward trajectory throughout the projected timeframe is largely fueled by developments in personalized medical treatments, ongoing efforts in pandemic readiness and reaction, the emergence of wearable infusion apparatuses, a noticeable movement favoring infusion-based care, and broader healthcare digitization initiatives.Key developments anticipated to shape this period involve the adoption of 5G network capabilities, the advent of quantum computing, the integration of the Internet of Things (IoT), advancements in wearable health technology, and the utilization of voice assistants alongside natural language processing.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20849&type=smp

Which Major Market Drivers Are Shaping The Future Of The Infusion Therapy Devices Market?

The escalating incidence of conditions categorized as long-term ailments—health issues persisting over a year that necessitate continuous medical management or restrict everyday functioning—is anticipated to fuel the expansion of the infusion therapy devices sector moving ahead. This heightened frequency of persistent diseases stems from diverse elements, including suboptimal lifestyle decisions, inactivity, poor eating patterns, and environmental factors, compounded by the proliferation of risk elements like obesity, tobacco use, and elevated stress levels. Infusion therapy apparatus plays a critical role in managing these protracted conditions through the accurate, regulated administration of therapeutic agents and fluids right into the circulatory system, thereby guaranteeing uniform and efficacious care for ailments such as diabetes, immune system dysfunctions, and malignancies, which ultimately leads to superior patient results, increased ease of use, and fewer mandatory hospital admissions. Illustratively, data from the US National Center for Biotechnology Information (NCBI) indicated in January 2023 an expectation that the population aged 50 and older suffering from a minimum of one chronic ailment will almost double by 2050, jumping from 71.522 million in 2020 to an estimated 142.66 million; consequently, the burgeoning rate of chronic illnesses stands as a key impetus for the market growth of infusion therapy equipment.

What Are The Major Segment Types Covered In The Infusion Therapy Devices Market?

The infusion therapy devicesmarket covered in this report is segmented –

1) By Product: Infusion Pumps, Intravenous (Iv) Sets, Cannulas, Needleless Connectors

2) By Mobility: Portable Infusion Pumps, Stationary Pumps

3) By Application: Oncology, Diabetes, Pain Management, Other Applications

4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Homecare, Other End-Users

Subsegments:

1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Insulin Infusion Pumps

2) By Intravenous (IV) Sets: Standard IV Sets, Extension IV Sets, IV Administration Sets with Filters

3) By Cannulas: Peripheral Intravenous (PIV) Cannulas, Central Venous Cannulas, Butterfly Cannulas

4) By Needleless Connectors: Positive Pressure Needleless Connectors, Neutral Pressure Needleless Connectors, Negative Pressure Needleless Connectors

How Are Emerging Market Trends Shaping The Infusion Therapy Devices Industry Landscape?

Key players within the infusion therapy devices sector are prioritizing the creation of novel approaches, such as pressure-enabled drug delivery (PEDD) technology, aimed at augmenting the therapeutic management of malignancies affecting the liver and pancreas. PEDD denotes a method of administering therapeutic agents where mechanical pressure facilitates their introduction into target tissues or organs, especially overcoming obstacles encountered with standard infusion techniques. As an illustration, in the month of November in 2024, TriSalus Life Sciences, a medical technology firm situated in the United States, introduced both the TriNav LV Infusion System and the TriGuide Guiding Catheters, thereby broadening their suite utilizing PEDD technology to refine the infusion of treatments, thus improving therapeutic choices and possibly yielding better results for individuals requiring care. The TriNav LV Infusion System boasts distinct attributes, including suitability for larger blood vessels ranging from 3.5 to 5.0 mm, which broadens the applicability of TriSalus’ Pressure-Enabled Drug Delivery (PEDD) method across a larger cohort of patients, extending its device compatibility for PEDD from vessels measuring 1.5 mm up to 5.0 mm and furnishing interventional radiologists with increased procedural selections. Furthermore, the TriGuide Guiding Catheters are equipped with a wider internal bore, a low-friction internal coating, and an inverted curve architecture engineered to simplify access via the femoral artery and boost the efficiency of procedures; initial feedback from practitioners indicates a satisfaction level of 97 percent, underscoring the apparatus’s efficacy and user-friendliness in cancer therapy applications.

Which Key Players Are Driving Competition In The Infusion Therapy Devices Market?

Major companies operating in the infusion therapy devices market are Roche Holding AG, Fresenius Kabi AG, Medtronic plc, Medline Industries Inc., Baxter International Inc., Terumo Corporation, Mindray Medical International Limited, Nipro Corporation, ICU Medical Inc., Cook Medical, Acelity L.P Inc., LivaNova PLC, Vygon S.A., AngioDynamics Inc., B. Braun Melsungen AG, Moog Medical Devices Group, Kangaroo, Vantage Medical Technologies, Alaris Medical Systems Inc., AccuVein Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/infusion-therapy-devices-global-market-report

What Regional Growth Trends Are Shaping The Infusion Therapy Devices Market Outlook?

North America was the largest region in the infusion therapy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infusion therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Infusion Therapy Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=20849&type=smp

Browse Through More Reports Similar to the Global Infusion Therapy Devices Market 2025, By The Business Research Company

Intravenous Infusion Pumps Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report

Ambulatory Iv Infusion Pumps Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ambulatory-iv-infusion-pumps-global-market-report

Implantable Infusion Pumps Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Projected CAGR for the Infusion Therapy Devices Market Size from 2025 to 2034?

The market size for infusion therapy devices has seen rapid expansion over the past few years. The projection is for an increase from $12.1 billion in 2024 to $13.33 billion in 2025, marking a compound annual growth rate (CAGR) of 10.2%. Factors such as a rise in hospital admissions, enhancements in healthcare facilities, government-led initiatives, the boom in medical tourism, and advantageous reimbursement policies have fuelled the growth during the historical period.

The market for infusion therapy devices is likely to witness substantial expansion in the coming years, with a projected growth to $19.82 billion by 2029, marking a compound annual growth rate (CAGR) of 10.4%. The anticipated growth during the forecast period can be credited to various factors such as the influence of personalized medicine, readiness and response to pandemics, the adoption of wearable infusion devices, the shift towards infusion therapy, and the digital transformation in the healthcare sector. The period is also anticipated to see significant trends such as 5G connectivity, quantum computing, incorporation of the internet of things (IoT), adoption of wearable health technology, and the use of voice assistants coupled with natural language processing.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20849&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Infusion Therapy Devices Market?

The growth of the infusion therapy devices market is anticipated to be fueled by the rising incidence of chronic diseases. These are enduring health issues that last for at least a year, necessitating continual medical care or restricting day-to-day activities. The rise in these diseases can be attributed to factors such as poor lifestyle decisions, sedentary behavior, unhealthy eating habits, and environmental factors, along with an increase in risk factors like obesity, smoking, and stress. Infusion therapy devices help manage chronic diseases by providing accurate, controlled delivery of medication and fluids straight into the bloodstream. This ensures reliable and effective treatment for conditions like diabetes, autoimmune disorders, and cancer, thereby enhancing patient outcomes, increasing comfort, and minimizing the requirement for regular hospital visits. For example, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, projected in January 2023 that by 2050, the population of individuals aged 50 and older with at least one chronic disease will escalate by 99.5%, growing from 71.522 million in 2020 to 142.66 million. Consequently, the escalating incidence of chronic diseases is stimulating the expansion of the infusion therapy devices market.

Which Key Market Segments Comprise the Infusion Therapy Devices Market and Drive Its Revenue Growth?

The infusion therapy devicesmarket covered in this report is segmented –

1) By Product: Infusion Pumps, Intravenous (Iv) Sets, Cannulas, Needleless Connectors

2) By Mobility: Portable Infusion Pumps, Stationary Pumps

3) By Application: Oncology, Diabetes, Pain Management, Other Applications

4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Homecare, Other End-Users

Subsegments:

1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Insulin Infusion Pumps

2) By Intravenous (IV) Sets: Standard IV Sets, Extension IV Sets, IV Administration Sets with Filters

3) By Cannulas: Peripheral Intravenous (PIV) Cannulas, Central Venous Cannulas, Butterfly Cannulas

4) By Needleless Connectors: Positive Pressure Needleless Connectors, Neutral Pressure Needleless Connectors, Negative Pressure Needleless Connectors

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20849&type=smp

Which Areas Are Leading Regions in the Infusion Therapy Devices Market Expansion Across the Globe?

North America was the largest region in the infusion therapy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infusion therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in theInfusion Therapy Devices Market Over the Coming Years?

Leading enterprises in the market for infusion therapy devices are channeling their efforts towards inventing cutting-edge solutions such as the pressure-enabled drug delivery (PEDD) technology to better the treatment procedures for liver and pancreatic tumors. Pressure-enabled drug delivery (PEDD) is a drug delivery method that utilizes pressure for the enhancement of therapeutic agent infusion into tissues or organs, especially where traditional methods might encounter difficulties. For instance, TriSalus Life Sciences, an American medical technology firm, debuted the TriNav LV Infusion System and TriGuide Guiding Catheters in November 2024, elongating its PEDD product lineup for optimized therapeutic delivery, thereby providing better treatment alternatives and possibly improving patient outcomes. The TriNav LV Infusion System, with its unique benefits such as larger blood vessels (3.5 to 5.0 mm), broadens the application of TriSalus’ Pressure-Enabled Drug Delivery (PEDD) technology to a wider patient demographic. By increasing PEDD device compatibility to 5.0 mm vessels from 1.5 mm, the launch provides interventional radiologists with increased treatments options. TriGuide Guiding Catheters are characterized by a larger inner diameter, a low friction lining, and a reversed curve structure for simpler femoral access and augmented procedural efficiency. The system’s effectiveness and user-friendliness in oncology treatments have resulted in a 97% satisfaction rate among early adopters.

View the full report here:

https://www.thebusinessresearchcompany.com/report/infusion-therapy-devices-global-market-report

How Is the Infusion Therapy Devices Market Conceptually Defined?

Infusion therapy devices refer to medical devices used to deliver fluids, medications, nutrients, or blood products directly into a patient’s bloodstream. Infusion therapy devices are utilized in highly versatile ways, improving patient care by providing accurate, controlled delivery of fluids, medications, and nutrition.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20849

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Infusion Therapy Devices Market?

The market size of infusion therapy devices has experienced a swift expansion in the last few years. The size is set to increase from $12.10 billion in 2024 to $13.43 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.0%. Factors contributing to the growth during the historical period include a rise in hospital admissions, advancements in healthcare infrastructure, governmental initiatives, growth in medical tourism, and relevant reimbursement policies.

What Growth Rate Is Forecasted for the Infusion Therapy Devices Market by 2029?

The market size for infusion therapy devices is predicted to experience a swift expansion in the coming years, reaching a value of $20.11 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 10.6%. The projected growth during the forecast period can be linked to the influence of personalized medicine, preparedness and response to pandemics, wearable infusion devices, a shift towards infusion therapy, and the digitization of healthcare. Key trends to look out for during this period include 5G connectivity, quantum computing, the incorporation of the internet of things (IoT), wearable health technology, as well as voice assistants and natural language processing.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20849&type=smp

Which Key Companies Are Shaping the Future of the Infusion Therapy Devices Market?

Major companies operating in the infusion therapy devices market are Roche Holding AG, Fresenius Kabi AG, Medtronic plc, Medline Industries Inc., Baxter International Inc., Terumo Corporation, Mindray Medical International Limited, Nipro Corporation, ICU Medical Inc., Cook Medical, Acelity L.P Inc., LivaNova PLC, Vygon S.A., AngioDynamics Inc., B. Braun Melsungen AG, Moog Medical Devices Group, Kangaroo, Vantage Medical Technologies, Alaris Medical Systems Inc., AccuVein Inc.

Which Factors Are Driving Demand in the Infusion Therapy Devices Industry?

The surge in chronic diseases is anticipated to spur the development of the infusion therapy devices market in the coming times. Chronic diseases are enduring health problems that persist for over a year, requiring routine medical care or restraining daily life activities. The rising occurrence of such diseases could be attributed to poor lifestyle choices, inactive patterns, substandard diets, and environmental elements, along with an increase in risk contributors such as obesity, smoking, and stress. Infusion therapy devices help in managing chronic illnesses by delivering medicaments and fluids directly into the bloodstream with accurate control, ascertaining consistent and effective treatment for disorders such as diabetes, autoimmune diseases, and cancer. This enhances patient outcomes, convenience, and minimizes frequent hospital visits. For instance, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, projected in January 2023 that by 2050, there would be a remarkable 99.5% increase in people aged 50 or above having at least one chronic illness, escalating from 71.522 million in 2020 to 142.66 million. Hence, the escalating occurrence of chronic diseases is propelling the infusion therapy devices market’s progress.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20849&type=smp

How Is the Infusion Therapy Devices Market Segmented by Several Divisions?

The infusion therapy devices market covered in this report is segmented –

1) By Product: Infusion Pumps, Intravenous (Iv) Sets, Cannulas, Needleless Connectors

2) By Mobility: Portable Infusion Pumps, Stationary Pumps

3) By Application: Oncology, Diabetes, Pain Management, Other Applications

4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Homecare, Other End-Users

Subsegments:

1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Insulin Infusion Pumps

2) By Intravenous (IV) Sets: Standard IV Sets, Extension IV Sets, IV Administration Sets with Filters

3) By Cannulas: Peripheral Intravenous (PIV) Cannulas, Central Venous Cannulas, Butterfly Cannulas

4) By Needleless Connectors: Positive Pressure Needleless Connectors, Neutral Pressure Needleless Connectors, Negative Pressure Needleless Connectors

What are the Emerging Market Trends Driving the Growth of the Infusion Therapy Devices Industry?

Leading companies in the infusion therapy devices market are directing their efforts towards creating innovative solutions like the pressure-enabled drug delivery (PEDD) technology. This novel technology is set up to improve treatments for liver and pancreatic tumors. The PEDD technology uses pressure to enhance the delivery of therapeutic agents into tissues or organs, proving to be more efficient in areas where traditional methods may encounter difficulties. For example, in November 2024, the medical technology firm based in the US, TriSalus Life Sciences, introduced the TriNav LV Infusion System and TriGuide Guiding Catheters. This broadened the company’s PEDD offerings, improving delivery, expanding treatment choices, and potentially enhancing patient outcomes. The TriNav LV Infusion System has distinctive features such as larger blood vessels (3.5 to 5.0 mm), making TriSalus’ PEDD technology available to a larger group of patients. The launch expanded the PEDD device’s compatibility to vessels ranging from 1.5 mm to 5.0 mm, giving interventional radiologists more options for treatments. The TriGuide Guiding Catheters are designed with a larger inner diameter, a slick lining, and a reversed curve design for a simpler femoral access and better procedural efficacy. Preliminary users reported a satisfaction rate of 97%, reinforcing the system’s efficiency and user-friendliness in oncology treatments.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/infusion-therapy-devices-global-market-report

Which Regions Are Driving Growth in the Infusion Therapy Devices Market?

North America was the largest region in the infusion therapy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infusion therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20849

This Report Delivers Insight On:

1. How big is the infusion therapy devices market, and how is it changing globally?

2. Who are the major companies in the infusion therapy devices market, and how are they performing?

3. What are the key opportunities and risks in the infusion therapy devices market right now?

4. Which products or customer segments are growing the most in the infusion therapy devices market?

5. What factors are helping or slowing down the growth of the infusion therapy devices market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Are the Projected Market Size and Growth Rates for the Infusion Therapy Devices Market From 2025 To 2029?

The market size of infusion therapy devices has expanded significantly in the past few years. The market, which is anticipated to escalate from $12.10 billion in 2024 to $13.43 billion in 2025, will witness a compound annual growth rate (CAGR) of 11.0%. Factors such as rising hospital admissions, enhancements in healthcare infrastructure, governmental initiatives, the growth of medical tourism, and well-defined reimbursement policies contributed to the growth in the historic period.

The market size of infusion therapy devices is predicted to experience exponential expansion in the approaching years. It’s projected to balloon to $20.11 billion by 2029, with a compound annual growth rate (CAGR) of 10.6%. The surge during the forecast period can be linked to the influence of personalized medicine, readiness and reaction to pandemics, adoption of wearable infusion devices, transition towards infusion therapy, and digitalization in healthcare. Noteworthy trends in the forecast period encompass 5g connectivity, quantum computing, integration of the internet of things (IoT), the rise of wearable health technology, and the utilization of voice assistants and natural language processing.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20849&type=smp

What Are the Core Market Drivers Propelling Growth in the Infusion Therapy Devices Industry?

The rise in chronic diseases is set to fuel the expansion of the infusion therapy devices market. Chronic diseases are defined as enduring health issues that last for more than a year, demanding continuous medical supervision or inhibiting regular everyday functions. Unhealthy lifestyle choices, inactive routines, poor diets, and environmental factors can contribute to the growing prevalence of these chronic diseases, along with increased risk factors like obesity, smoking, and stress. Infusion therapy devices aid in the management of chronic diseases by consistently and precisely administering drugs and fluids directly into the bloodstream. This provides an effective treatment for conditions such as diabetes, autoimmune diseases, and cancer, and enhances patient results, convenience, and lessens the requirement for regular hospital visits. For example, in January 2023, the National Center for Biotechnology Information (NCBI), a National Library of Medicine based in the US, predicted that by 2050, there will be a 99.5% increase in people 50 years old and above with at least one chronic disease, from 71.522 million in 2020 to 142.66 million. Hence, the rising prevalence of chronic diseases is stimulating the expansion of the infusion therapy devices market.

How Is the Infusion Therapy Devices Market Segmented?

The infusion therapy devices market covered in this report is segmented –

1) By Product: Infusion Pumps, Intravenous (Iv) Sets, Cannulas, Needleless Connectors

2) By Mobility: Portable Infusion Pumps, Stationary Pumps

3) By Application: Oncology, Diabetes, Pain Management, Other Applications

4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Homecare, Other End-Users

Subsegments:

1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Insulin Infusion Pumps

2) By Intravenous (IV) Sets: Standard IV Sets, Extension IV Sets, IV Administration Sets with Filters

3) By Cannulas: Peripheral Intravenous (PIV) Cannulas, Central Venous Cannulas, Butterfly Cannulas

4) By Needleless Connectors: Positive Pressure Needleless Connectors, Neutral Pressure Needleless Connectors, Negative Pressure Needleless Connectors

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20849&type=smp

Which Regions Are Driving the Next Phase of the Infusion Therapy Devices Market Growth?

North America was the largest region in the infusion therapy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infusion therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Strategic Trends Steering the Infusion Therapy Devices Market Direction?

Leading corporations in the infusion therapy devices market are striving towards the creation of unique solutions, such as the technology of pressure-enabled drug delivery (PEDD), to improve treatments for liver and pancreatic tumors. PEDD is a revolutionary drug delivery strategy that utilizes pressure to augment the infusion of therapeutic agents into tissues or organs, especially where traditional techniques may encounter difficulties. For example, in November 2024, TriSalus Life Sciences, a medical technology firm based in the US, unveiled the TriNav LV Infusion System and TriGuide Guiding Catheters. These additions to its PEDD product line aim to enhance therapeutic delivery and expand treatment alternatives, potentially leading to better patient outcomes. The TriNav LV Infusion System boasts special features like enlarged blood vessels (3.5 to 5.0 mm), extending the implementation of TriSalus’ PEDD technology to a wider patient demographic. This launch broadens PEDD device adaptability to vessel sizes ranging from 1.5 mm to 5.0 mm, presenting interventional radiologists with more treatment alternatives. The TriGuide Guiding Catheters have an increased inner diameter, a frictionless lining, and a mirrored curve design for simpler femoral access and heightened procedural efficiency. Preliminary users have reported a 97% satisfaction rate, which underscores the system’s efficiency and user-friendly nature in oncology treatments.

View the full report here:

https://www.thebusinessresearchcompany.com/report/infusion-therapy-devices-global-market-report

How Is the Infusion Therapy Devices Market Defined and What Are Its Core Parameters?

Infusion therapy devices refer to medical devices used to deliver fluids, medications, nutrients, or blood products directly into a patient’s bloodstream. Infusion therapy devices are utilized in highly versatile ways, improving patient care by providing accurate, controlled delivery of fluids, medications, and nutrition.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20849

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theInfusion Therapy Devices Market?

The rise in chronic diseases, which are long-term health conditions requiring continuous medical care, or impeding daily activities, is anticipated to drive the infusion therapy devices market’s expansion. The escalating instances of chronic diseases can be attributed to poor lifestyle choices, sedentary behavior, unhealthy eating habits, and environmental factors, along with increased risk factors like obesity, smoking, and stress. Infusion therapy devices offer a solution to manage chronic diseases by delivering medications and fluids directly into the bloodstream in a controlled, precise manner. This method ensures continual and effective treatment for various conditions including diabetes, autoimmune disorders, and cancer, enhancing patient convenience, improving outcomes, and curtailing frequent hospital visits. For instance, data from the National Center for Biotechnology Information (NCBI), US-based National Library of Medicine, predicts that by 2050, individuals aged 50 years and above suffering from at least one chronic disease will rise by 99.5%, increasing from 71.522 million in 2020 to 142.66 million. Thus, the upsurge in chronic diseases is promoting the growth of the infusion therapy devices market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20849&type=smp

What is the Predicted Annual Growth Rate of theInfusion Therapy Devices Market Impact Industry Trends by 2034?

There has been brisk growth in the market size of infusion therapy devices in the past few years. The market, which is projected to be worth $12.10 billion in 2024, is expected to surge to $13.43 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 11.0%. The impressive growth rate during the historical period is a reflection of factors like the rise in hospital admissions, enhanced healthcare facilities, government-led drives, medical tourism, and revised reimbursement policies.

We anticipate considerable expansion in the infusion therapy devices market in the upcoming years. The market is predicted to surge to $20.11 billion by 2029, marking a compound annual growth rate (CAGR) of 10.6%. This growth through the forecast period could be ascribed to factors such as the influence of personalized medicine, readiness and response to pandemics, the adoption of wearable infusion devices, a shift towards infusion therapy, and the digitalization of healthcare. Dominant trends during the forecast period encompass 5G connectivity, quantum computing, integration of the internet of things (IoT), wearable health technology, and voice assistants coupled with natural language processing.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20849

What Key Market Trends and Innovations Are Shaping the Future of theInfusion Therapy Devices Industry?

Leading organizations within the infusion therapy devices market are prioritizing the creation of innovative solutions such as pressure-enabled drug delivery (PEDD) technology to improve treatments for liver and pancreatic tumors. The PEDD technology is a drug delivery system that uses pressure to facilitate the infusion of therapeutic agents into organs or tissues, particularly where traditional methods may struggle. For example, TriSalus Life Sciences, a medical technology firm based in the U.S, introduced the TriNav LV Infusion System and TriGuide Guiding Catheters in November 2024. This extended their PEDD product range aimed at optimizing therapeutic delivery, enhancing treatment alternatives, and possibly boosting patient outcomes. Unique features of the TriNav LV Infusion System include larger blood vessels (3.5 to 5.0 mm), making TriSalus’s PEDD technology available to a wider range of patients. This introduction expands PEDD device compatibility from 1.5 mm to 5.0 mm vessels, providing more treatment options for interventional radiologists. The TriGuide Guiding Catheters offer a larger internal diameter, a slick lining, and a reverse curve design to facilitate femoral access and boost procedural efficiency. Initial users have expressed a 97% satisfaction rate, demonstrating the system’s effectiveness and user-friendliness in cancer treatments.

Which Companies Are Leading the Charge in Expanding theInfusion Therapy Devices Market Growth?

Major companies operating in the infusion therapy devices market are Roche Holding AG, Fresenius Kabi AG, Medtronic plc, Medline Industries Inc., Baxter International Inc., Terumo Corporation, Mindray Medical International Limited, Nipro Corporation, ICU Medical Inc., Cook Medical, Acelity L.P Inc., LivaNova PLC, Vygon S.A., AngioDynamics Inc., B. Braun Melsungen AG, Moog Medical Devices Group, Kangaroo, Vantage Medical Technologies, Alaris Medical Systems Inc., AccuVein Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/infusion-therapy-devices-global-market-report

How is the Global Infusion Therapy Devices Market Segemented?

The infusion therapy devices market covered in this report is segmented –

1) By Product: Infusion Pumps, Intravenous (Iv) Sets, Cannulas, Needleless Connectors

2) By Mobility: Portable Infusion Pumps, Stationary Pumps

3) By Application: Oncology, Diabetes, Pain Management, Other Applications

4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Homecare, Other End-Users

Subsegments:

1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Insulin Infusion Pumps

2) By Intravenous (IV) Sets: Standard IV Sets, Extension IV Sets, IV Administration Sets with Filters

3) By Cannulas: Peripheral Intravenous (PIV) Cannulas, Central Venous Cannulas, Butterfly Cannulas

4) By Needleless Connectors: Positive Pressure Needleless Connectors, Neutral Pressure Needleless Connectors, Negative Pressure Needleless Connectors

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=20849&type=smp

Which Geographics are Influencing the Growth of the Infusion Therapy Devices Market?

North America was the largest region in the infusion therapy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infusion therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Infusion Therapy Devices Market 2025, By The Business Research Company:

foam blowing agents Global Market Report 2025

https://thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report

Ambulatory Iv Infusion Pumps Global Market Report 2025

https://thebusinessresearchcompany.com/report/ambulatory-iv-infusion-pumps-global-market-report

Implantable Infusion Pumps Global Global Market Report 2025

https://thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: